Growth Hormones
PDL Reference Documents
- Growth Hormone in Adults - Apr 06, 2023
- Growth Hormone PA Update - Dec 01, 2022
- Growth Hormones Class Update/New Drug Evaluation - Dec 02, 2021
- Growth Hormones - Jun 03, 2021
- Growth Hormone - Nov 29, 2018
- Growth Hormone Literature Scan - Sep 28, 2017
- Growth Hormones - Sep 29, 2016
- Growth Hormones - Sep 24, 2015
- Growth Hormones - Sep 23, 2014
- Class Scan: Growth Hormone - Sep 26, 2013
- Class Scan: Growth Hormones - Sep 27, 2012
PDL Status Values
Y = preferred
N = non-preferred. Non-preferred drugs listed as N but without clinical drug use criteria are subject to the
Non-Preferred Drugs in Select PDL Classes prior authorization criteria.
New drugs will be listed as N until reviewed by the P&T Committee and are subject to the
New Drug Policy.
V = voluntary non-preferred. Non-preferred mental health drugs are listed as V and prior authorization is not required.
Null (i.e. blank) = indicates the class or specific drug has not been reviewed for PDL placement.
To request a Prior Authorization, please use this form.
Generic Name | Brand Name | Form | PDL Status |
Current Drug Use Criteria | New Drug Evaluation & Updates |
---|---|---|---|---|---|
somatropin | GENOTROPIN | CARTRIDGE | Y | PA Document | |
somatropin | NORDITROPIN FLEXPRO | PEN INJCTR | Y | PA Document | |
somatropin | GENOTROPIN | SYRINGE | Y | PA Document | |
lonapegsomatropin-tcgd | SKYTROFA | CARTRIDGE | N | PA Document | |
somapacitan-beco | SOGROYA | PEN INJCTR | N | PA Document | |
somatrogon-ghla | NGENLA | PEN INJCTR | N | PA Document | |
somatropin | OMNITROPE | CARTRIDGE | N | PA Document | |
somatropin | HUMATROPE | CARTRIDGE | N | PA Document | |
somatropin | NUTROPIN AQ NUSPIN | PEN INJCTR | N | PA Document | |
somatropin | ZOMACTON | VIAL | N | PA Document | |
somatropin | SEROSTIM | VIAL | N | PA Document | |
somatropin | OMNITROPE | VIAL | N | PA Document |